首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1414327

2024 年神經調節體內設備全球市場報告

Internal Neuromodulation Devices Global Market Report 2024

出版日期: 按訂單生產 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，神經調節體內設備的市場規模強勁成長。將從2023年的24.7億美元成長到2024年的26.6億美元，複合年成長率為7.7%。這種時間的延長是由於慢性疼痛管理、人口老化、對臨床研究和臨床試驗的日益關注、神經系統疾病的流行以及患者對關鍵字認知和接受度的提高等因素造成的。

神經調節體內設備市場規模預計在未來幾年將強勁成長。 2028年，這一數字將以7.9%的複合年成長率成長至36.1億美元。預測期內的預期成長是由個人化醫療趨勢、醫療保健支出增加、行業聯盟和合作夥伴關係、對患者結果和現實世界證據的關注以及監管環境的變化所推動的。預測期內預計的主要趨勢包括小型化和植入技術的進步、無線連接和遠端監控的整合、神經調節的擴展應用、用於精確調節的封閉回路型系統的開發以及以患者為中心的設計。

由於神經系統疾病盛行率的預期增加，神經調節體內設備市場預計在可預見的未來將成長。神經系統疾病包括影響神經系統的多種疾病，包括大腦、脊髓和周邊神經。神經調節內部裝置透過向神經系統的特定區域提供電刺激來緩解慢性疼痛、運動障礙和情緒障礙等症狀，在神經和精神疾病的治療中發揮重要作用。這些設備透過減輕症狀和使日常生活變得更加輕鬆，有助於改善患者的生活品質。例如，2021年，美國疾病管制與預防中心宣布，阿茲海默症影響約620萬65歲以上的美國，到2060年，這一數字將增加近三倍，達到1,400萬。預計此外，65 歲以後，發病率每五年加倍。因此，神經系統疾病的日益普及正在推動神經調節體內設備市場的成長。

預計腦腫瘤盛行率的上升將推動神經調節體內設備市場的擴張。腦腫瘤是發生在大腦和脊髓中的一組不同的腫瘤，對理解和治療提出了複雜的挑戰。神經調節體內設備已成為治療多種腦部疾病的一種有前途的治療解決方案，可將電刺激或其他型態的能量直接傳遞到大腦的特定區域，以調節神經細胞活動並提高治療效果。根據美國腦腫瘤協會報告，到 2022 年，大約有 94,390 名美國將被診斷出患有腦腫瘤，到 2023 年，估計將有 18,990 人死於惡性腦腫瘤。因此，腦腫瘤發生率的增加是神經調節體內設備市場成長的催化劑。

2023年，北美是神經調節體內設備市場最大的地區。在全球神經調節體內設備市場報告中，亞太地區預計將成為預測期內成長最快的地區。神經調節體內設備市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

全球神經調節體內設備市場，按類型、表現和預測細分，2018-2023、2023-2028、2033
脊髓刺激設備
深部腦部刺激器
薦骨神經刺激器
迷走神經刺激設備
胃神經刺激設備
全球神經調節體內設備市場，依技術類型、表現及預測細分，2018-2023、2023-2028、2033
內部神經調節
體外神經調節
全球神經調節體內設備市場，依生物材料細分、性能與預測，2018-2023、2023-2028、2033
金屬生物材料
高分子生物材料
陶瓷生物材料
全球神經調節體內設備市場，按應用、性能和預測細分，2018-2023、2023-2028、2033
腰部手術失敗綜合症
帕金森氏症
尿失禁
癲癇
胃輕癱
全球神經調節體內設備市場，依最終用戶細分、性能和預測，2018-2023、2023-2028、2033
醫院
診所
家庭保健
社區健康保健

第 7 章區域與國家分析

全球神經調節體內設備市場，按地區、績效及預測，2018-2023、2023-2028、2033
全球神經調節體內設備市場，按國家、表現和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭形勢及公司概況

神經調節體內設備市場競爭形勢
神經調節體內設備市場公司概況
- Medtronic plc
- Boston Scientific Corporation
- Cyberonics Inc.
- BioControl Medical Ltd.
- Aleva Neurotherapeutics SA

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章重大併購

第34章未來前景與可能性分析

第35章附錄

簡介目錄

Product Code: r11837

“Internal Neuromodulation Devices Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on internal neuromodulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for internal neuromodulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The internal neuromodulation devices market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Spinal Cord Stimulator; Deep Brain Stimulator; Sacral Nerve Stimulator; Vagus Nerve Stimulator; Gastric Neuro Stimulator
2) By Technology Type: Internal Neuromodulation; External Neuromodulation
3) By Biomaterial: Metallic Biomaterials; Polymeric Biomaterials; Ceramic Biomaterials
4) By Application: Failed Back Surgery Syndrome; Parkinson's Disease; Urinary Incontinence; Epilepsy; Gastroparesis
5) By End-User: Hospitals; Clinics; Home Healthcare; Community Healthcare
Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Cyberonics Inc.; BioControl Medical Ltd.; Aleva Neurotherapeutics SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Internal neuromodulation devices are a category of medical devices that are surgically implanted inside the body to deliver electrical stimulation to specific areas of the nervous system, offering relief for various neurological and psychiatric conditions.

The primary types of internal neuromodulation devices include spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and gastric neurostimulators. These devices utilize different technologies, encompassing both internal and external neuromodulation, along with biomaterials such as metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. They find applications in treating conditions such as failed back surgery syndrome, Parkinson's disease, urinary incontinence, epilepsy, and gastroparesis. The end-users of these devices span hospitals, clinics, home healthcare, and community healthcare.

The internal neuromodulation devices market research report is one of a series of new reports from The Business Research Company that provides internal neuromodulation devices market statistics, including internal neuromodulation devices industry global market size, regional shares, competitors with a internal neuromodulation devices market share, detailed internal neuromodulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the internal neuromodulation devices industry. This internal neuromodulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The internal neuromodulation devices market size has grown strongly in recent years. It will grow from $2.47 billion in 2023 to $2.66 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The expansion observed in the historical period can be attributed to factors such as the management of chronic pain, the aging population, increased focus on clinical research and trials, the prevalence of neurological disorders, and growing patient awareness and acceptance of internal neuromodulation devices.

The internal neuromodulation devices market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The anticipated growth in the forecast period can be attributed to trends in personalized medicine, increasing healthcare expenditure, collaborations and partnerships within the industry, a focus on patient outcomes and real-world evidence, and changes in the regulatory landscape. Key trends expected in the forecast period encompass advancements in miniaturization and implantable technology, the integration of wireless connectivity and remote monitoring, expanded applications for neuromodulation, the development of closed-loop systems for precise modulation, and a heightened focus on patient-centric design.

The anticipated increase in the prevalence of neurologic diseases is poised to drive the growth of the internal neuromodulation devices market in the foreseeable future. Neurologic diseases encompass a wide range of disorders affecting the nervous system, including the brain, spinal cord, and peripheral nerves. Internal neuromodulation devices play a crucial role in treating neurological and psychiatric conditions by administering electrical stimulation to specific areas of the nervous system, offering relief from symptoms such as chronic pain, movement disorders, and mood disorders. These devices contribute to enhancing patients' quality of life by alleviating symptoms and facilitating daily activities. For example, in 2021, the Centers for Disease Control and Prevention reported that Alzheimer's disease affected approximately 6.2 million Americans aged 65 and older, a number expected to nearly triple to 14 million by 2060. Additionally, the incidence of the disease doubles every five years after the age of 65. Thus, the increasing prevalence of neurologic diseases is a driving force behind the growth of the internal neuromodulation devices market.

The rising incidence of brain cancers is anticipated to fuel the expansion of the internal neuromodulation devices market. Brain cancer, a diverse group of tumors originating in the brain or spinal cord, poses complex challenges for understanding and treatment. Internal neuromodulation devices emerge as a promising therapeutic solution for various brain disorders, delivering electrical stimulation or other forms of energy directly to specific brain regions to modulate neuronal activity and induce therapeutic effects. In 2022, the National Brain Tumor Society reported an expected diagnosis of brain tumors in approximately 94,390 Americans, with an estimated 18,990 deaths from malignant brain tumors in 2023. Thus, the growing incidence of brain cancers serves as a catalyst for the growth of the internal neuromodulation devices market.

A prominent trend gaining traction in the internal neuromodulation devices market is product innovation. Major companies in this segment are actively engaged in developing new technologies to maintain their market positions. For instance, in March 2023, Ireland-based medical equipment manufacturer Neuromod Device Ltd. announced that its Lenire system had received De Novo clearance from the US Food and Drug Administration (FDA). The Lenire system employs a combination of sound stimulation and tongue stimulation to treat tinnitus, a neurological disorder characterized by ringing in the ears. This innovative system uses a dual-pronged approach to neurostimulation, utilizing Bluetooth headphones to play unique sounds stimulating the auditory nerve, while Neuromod's Tonguetip device transmits moderate electrical stimulation to the tongue's surface. This technology provides otolaryngologists with an innovative tool to recommend to patients experiencing a moderately negative impact on their lives due to tinnitus.

Major companies in the internal neuromodulation devices market are concentrating on developing technological innovations, including digital health apps, to gain a competitive edge. Digital health apps are software applications designed to deliver health-related services and information to users on mobile devices. For example, in July 2022, US-based medical device provider Abbott Laboratories launched the NeuroSphere Virtual Clinic, a groundbreaking technology allowing patients with Abbott's neurostimulation devices to remotely communicate with doctors. This feature enables patients to ensure proper settings, functionality, and receive new treatment settings via secure in-app video chat and integrated remote programming. The platform provides real-time data to physicians about patients' device usage and pain levels.

In March 2022, US-based medical equipment manufacturer Electromedical Products International (EPI) acquired Pulvinar Neuro for an undisclosed amount. Through this acquisition, Pulvinar Neuro gains enhanced capabilities for promoting its patented technologies, such as transcranial alternating current stimulation (tACS). Additionally, the acquisition enhances its cloud-enabled digital treatments for mental and neurological conditions and customized feedback stimulation. Pulvinar Neuro is a US-based medical technology company specializing in deep brain stimulation (DBS) systems for treating neurological and psychiatric disorders.

Major companies operating in the internal neuromodulation devices market report are Medtronic plc, Boston Scientific Corporation, Cyberonics Inc., BioControl Medical Ltd., Aleva Neurotherapeutics SA, Bioness Inc., Uroplasty Inc., Abbott Laboratories, St. Jude Medical Inc., EnteroMedics Inc., Micron Medical Corporation, LivaNova plc, NeuroPace Inc., Synapse Biomedical Inc., Soterix Medical Inc., Accellent Inc., Neuros Medical Inc., Nevro Corp., Nuvectra Corporation, Stimwave Technologies Incorporated, SPR Therapeutics, Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, MicroTransponder Inc., EndoStim Inc., NeuroMetrix Inc., Second Sight Medical Products Inc., Neurotech International Limited, Neuronix Ltd., Neuronoff Inc.

North America was the largest region in the internal neuromodulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the internal neuromodulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The internal neuromodulation devices market consists of sales of electrodes, leads, receivers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

1. Executive Summary

2. Internal Neuromodulation Devices Market Characteristics

3. Internal Neuromodulation Devices Market Trends And Strategies

4. Internal Neuromodulation Devices Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Internal Neuromodulation Devices Market Size and Growth

5.1. Global Internal Neuromodulation Devices Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Internal Neuromodulation Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Internal Neuromodulation Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Internal Neuromodulation Devices Market Segmentation

6.1. Global Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Neuro Stimulator
6.2. Global Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Internal Neuromodulation
External Neuromodulation
6.3. Global Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Metallic Biomaterials
Polymeric Biomaterials
Ceramic Biomaterials
6.4. Global Internal Neuromodulation Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Failed Back Surgery Syndrome
Parkinson's Disease
Urinary Incontinence
Epilepsy
Gastroparesis
6.5. Global Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Home Healthcare
Community Healthcare

7. Internal Neuromodulation Devices Market Regional And Country Analysis

7.1. Global Internal Neuromodulation Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Internal Neuromodulation Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Internal Neuromodulation Devices Market

8.1. Asia-Pacific Internal Neuromodulation Devices Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Internal Neuromodulation Devices Market

9.1. China Internal Neuromodulation Devices Market Overview
9.2. China Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Internal Neuromodulation Devices Market

10.1. India Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Internal Neuromodulation Devices Market

11.1. Japan Internal Neuromodulation Devices Market Overview
11.2. Japan Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Internal Neuromodulation Devices Market

12.1. Australia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Internal Neuromodulation Devices Market

13.1. Indonesia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Internal Neuromodulation Devices Market

14.1. South Korea Internal Neuromodulation Devices Market Overview
14.2. South Korea Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Internal Neuromodulation Devices Market

15.1. Western Europe Internal Neuromodulation Devices Market Overview
15.2. Western Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Internal Neuromodulation Devices Market

16.1. UK Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Internal Neuromodulation Devices Market

17.1. Germany Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Internal Neuromodulation Devices Market

18.1. France Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Internal Neuromodulation Devices Market

19.1. Italy Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Internal Neuromodulation Devices Market

20.1. Spain Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Internal Neuromodulation Devices Market

21.1. Eastern Europe Internal Neuromodulation Devices Market Overview
21.2. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Internal Neuromodulation Devices Market

22.1. Russia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Internal Neuromodulation Devices Market

23.1. North America Internal Neuromodulation Devices Market Overview
23.2. North America Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Internal Neuromodulation Devices Market

24.1. USA Internal Neuromodulation Devices Market Overview
24.2. USA Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Internal Neuromodulation Devices Market

25.1. Canada Internal Neuromodulation Devices Market Overview
25.2. Canada Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Internal Neuromodulation Devices Market

26.1. South America Internal Neuromodulation Devices Market Overview
26.2. South America Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Internal Neuromodulation Devices Market

27.1. Brazil Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Internal Neuromodulation Devices Market

28.1. Middle East Internal Neuromodulation Devices Market Overview
28.2. Middle East Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Internal Neuromodulation Devices Market

29.1. Africa Internal Neuromodulation Devices Market Overview
29.2. Africa Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Internal Neuromodulation Devices Market Competitive Landscape And Company Profiles

30.1. Internal Neuromodulation Devices Market Competitive Landscape
30.2. Internal Neuromodulation Devices Market Company Profiles
- 30.2.1. Medtronic plc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Boston Scientific Corporation
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Cyberonics Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. BioControl Medical Ltd.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Aleva Neurotherapeutics SA
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Internal Neuromodulation Devices Market Competitive Benchmarking

32. Global Internal Neuromodulation Devices Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Internal Neuromodulation Devices Market

34. Internal Neuromodulation Devices Market Future Outlook and Potential Analysis

34.1 Internal Neuromodulation Devices Market In 2028 - Countries Offering Most New Opportunities
34.2 Internal Neuromodulation Devices Market In 2028 - Segments Offering Most New Opportunities
34.3 Internal Neuromodulation Devices Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies